Pharma sales growth at Merck KGaA amid 'transformation'
This article was originally published in Scrip
Executive Summary
Merck KGaA, which is expecting 2015 to be a "challenging year" as it goes through a "transformation period," has reported a solid first quarter. The German chemicals and pharmaceuticals firm signed a major deal with Pfizer last year in the immune-oncology space.